8-K//Current report
Silo Pharma, Inc. 8-K
Accession 0001213900-25-062805
$SILOCIK 0001514183operating
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 4:30 PM ET
Size
293.4 KB
Accession
0001213900-25-062805
Documents
- 8-Kea0248611-8k_silo.htmPrimary
CURRENT REPORT
- EX-10.1ea024861101ex10-1_silo.htm
TERMINATION, COMMERCIAL EVALUATION LICENSE, AND OPTION AGREEMENT, DATED JULY 8, 2025, BY AND BETWEEN THE COMPANY AND THE UNIVERSITY OF MARYLAND, BALTIMORE
- EX-101.SCHsilo-20250708.xsd
XBRL SCHEMA FILE
- EX-101.LABsilo-20250708_lab.xml
XBRL LABEL FILE
- EX-101.PREsilo-20250708_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-062805-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0248611-8k_silo_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Silo Pharma, Inc.
CIK 0001514183
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001514183
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 4:30 PM ET
- Size
- 293.4 KB